Ligand earns Buy rating from Stifel for its royalty-based funding model and biotech partnerships amid strong revenue and earnings growth.

Cysteinyl leukotrienes (CysLTs) are potent bronchoconstrictors, playing pivotal roles in inflammatory diseases. These lipid ...

Fintel reports that on April 10, 2025, Stifel initiated coverage of Ligand Pharmaceuticals (NasdaqGM:LGND) with a Buy ...

Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies.

Keros plans on engaging with regulatory authorities, starting in the third quarter of 2025. Subject to the outcome of these regulatory interactions, Keros expects to initiate a Phase 2 clinical trial ...

US-based biopharmaceutical company Helicore Biopharma has dosed the first subject in a randomised, first-in-human Phase I ...

Laboratoire de Spectrométrie de Masse BioOrganique, CNRS, Université de Strasbourg, IPHC UMR 7178, Infrastructure Nationale de Protéomique ProFI - FR2048, 67087 Strasbourg, France ...

The White House maintains that President Donald Trump does not use an autopen to sign legally binding documents like pardons — after Trump accused former President Joe Biden of having used the ...

Abstract: Predicting protein-ligand binding affinities is a critical problem in drug discovery and design. A majority of existing methods fail to accurately characterize and exploit the geometrically ...

Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India ...